InBody

InBody is a South Korean health-technology company and its own brand of body composition analyzers. Founded in 1996 by Dr. Ki-Chul Cha, the company developed its business around body composition analysis technology. Its official history says it commercialized the InBody2.0 analyzer in 1996, describing it as the world’s first body composition analyzer of its kind. The company presents accuracy and reproducibility as central attributes of its technology and says its analyzers are used in fitness centers and hospitals. The company’s offering extends beyond professional body composition analyzers. Its stated business areas include blood pressure monitors, BWA body water analyzers, and home-use products and solutions. InBody introduced a home-use body composition analyzer in 2006 as it entered the consumer market. Its current website presents the InBody analyzer, BWA, and home-use products as key product areas, and describes the company as a worldwide leader in body composition technology. InBody is headquartered in Seoul, South Korea. The company reports a global presence spanning more than 110 countries, with subsidiaries or offices named in regions including the United States, Japan, China, India, Asia, the United Kingdom, Germany, Europe, and Mexico. Its products have been used in research, and the company says hundreds of papers have been published using InBody equipment. The official website identifies Dr. Ki-Chul Cha as founder and CEO. The available evidence does not establish the company’s parent, ownership structure, or listing status.

InBody’s corporate history begins in South Korea in 1996. The company’s official history records the establishment of Biospace Co., Ltd. that year and the successful commercialization of the InBody2.0 body composition analyzer. It attributes the technology’s development to founder Dr. Ki-Chul Cha, who sought to address limitations in conventional body composition analysis. The company describes the resulting device as a pioneering analyzer designed for accuracy and reproducibility. Its About Us page says Cha recognized in the early 1990s that available bioelectrical impedance analysis devices were limited and often inaccurate, and that his mechanical-engineering background informed his effort to develop a better instrument. In 1997, the company established a bioengineering research center. It began building an international business early: in 2000 it established subsidiary offices in the United States and Japan. The official history says the company trained employees as product experts to develop markets for its products and educate customers. A factory was completed in Cheonan in 2002. In 2005, the company unified its body composition analyzer brands under the InBody series. In 2006, InBody launched a home-use body composition analyzer to enter the consumer market and broaden its product line. The company framed the home product around cumulative tracking of body composition rather than treating it as a substitute for a weight scale. It established a subsidiary office in China in 2008. In 2012, the company received the 10 Million Dollar Export Tower on Trade Day, according to its official history. The corporate name changed to InBody Co., Ltd. in 2014. The company continued expanding its international presence, establishing subsidiary offices in Malaysia and India in 2016 and in the Netherlands, under InBody Europe, in 2017. Its Cheonan production factory was expanded in 2017. The current company describes itself as operating across more than 110 countries, with named offices and subsidiaries across multiple regions. It markets body composition analyzers alongside BWA body water analyzers, blood pressure monitors, and home-use solutions. Its official website identifies Dr. Ki-Chul Cha as CEO and describes the brand’s analyzers as used in fitness centers and hospitals. The supplied history excerpt begins a 2018 entry but does not provide its details, so no further event for that year is stated here.

• 2017

  InBody Europe established; Cheonan factory expanded

• 2016

  Subsidiary offices established in Malaysia and India

• 2014

  Company name changed to InBody Co., Ltd.

• 2012

  Awarded the 10 Million Dollar Export Tower

• 2008

  Subsidiary office established in China

• 2006

  Home-use body composition analyzer launched

• 2005

  Body composition analyzer brands unified as the InBody series

• 2002

  Cheonan factory completed

• 2000

  Subsidiary offices established in the United States and Japan

• 1997

  Bioengineering research center established

• 1996

  Biospace Co., Ltd. established; InBody2.0 commercialized

A health-technology brand focused on body composition analysis, emphasizing accuracy, reproducibility, and use in professional and home settings.

• InBody body composition analyzers

  The company’s own-brand analyzers, described as used in fitness centers and hospitals.

• BWA Body Water Analyzer

  A body water analysis product line presented on the company website.

• Home-use products

  Home-use health and body composition products, including a home-use body composition analyzer launched in 2006.

• Blood pressure monitors

  Listed by the company as a business area.

• 2006

  Entered the home-use consumer marketOther

• 2005

  Unified body composition analyzer brandingOther

1. 1InBody homepageinbody.com
2. 2InBody historyinbody.com
3. 3InBody About Usinbody.com
4. 4InBody storyinbody.com